Therefore, it becomes important to discriminate tumor antigen–specific Th cells that persist in tumors from bystander CD4+ T cells that are recruited into the TME under proinflammatory conditions, but fail to be activated through their T cell receptor (TCR). Here, CD4 is linked to neoplasm.